Assembly Biosciences (ASMB) Change in Receivables (2017 - 2026)
Assembly Biosciences' (ASMB) quarterly Change in Receivables came in at -$523000.0 in Q1 2026, down 943.55% quarter-over-quarter from $62000.0 in Q4 2025.
Assembly Biosciences (ASMB) Change in Receivables (2017 - 2026) Analysis & Trends
Assembly Biosciences' Change in Receivables history runs 10 years deep, the most recent figure standing at -$523000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$523000.0 in Q1 2026; TTM through Mar 2026 was $451000.0, a 1148.84% increase from a year earlier, with the FY2025 full-year figure at $974000.0, up 2365.12% from the prior year.
- Change in Receivables declined to -$523000.0 in Q1 2026 per ASMB's latest filing, from $62000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $912000.0 in Q3 2025 and bottomed at -$523000.0 in Q1 2026.
- The 5-year median for Change in Receivables is -$22000.0 (2022), against an average of $9583.3.
- Across the five-year window, Change in Receivables surged 118.31% in 2022 and plunged 37400.0% in 2023, its largest moves.
- Year by year, Change in Receivables stood at -$302000.0 in 2022, then jumped by 114.24% to $43000.0 in 2023, then sank by 200.0% to -$43000.0 in 2024, then surged by 244.19% to $62000.0 in 2025, then tumbled by 943.55% to -$523000.0 in 2026.
- Per Business Quant, the three latest ASMB Change in Receivables figures stand at -$523000.0 (Q1 2026), $62000.0 (Q4 2025), and $912000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | -523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -523,000.00 |
| Mar 31, 2026 | -523,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | -342,000.00 |
| Sep 30, 2023 | -342,000.00 |
| Jun 30, 2023 | -375,000.00 |
| Jun 30, 2023 | -375,000.00 |
| Mar 31, 2023 | -227,000.00 |
| Mar 31, 2023 | -227,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Sep 30, 2022 | 723,000.00 |
| Sep 30, 2022 | 723,000.00 |